FHH-Chr 15BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
9 |
383.93 |
beats/min |
7.94 |
23.83 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52485 |
482 |
FHH-Chr 15BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
9 |
2.92 |
ng/ml/h |
0.71 |
2.13 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52879 |
482 |
FHH-Chr 15BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
9 |
160.32 |
mmHg |
5.98 |
17.94 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52532 |
482 |
FHH-Chr 15BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
9 |
21.01 |
mEq/d |
1.52 |
4.55 |
flame atomic emission spectrometry |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52781 |
482 |
FHH-Chr 15BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
-6.99 |
null |
0.09 |
0.23 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56888 |
522 |
FHH-Chr 15BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54879 |
522 |
FHH-Chr 15BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
0.03 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54898 |
522 |
FHH-Chr 15BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
9 |
232.75 |
mg/d |
44.36 |
133.08 |
automated urine total protein analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52095 |
482 |
FHH-Chr 15BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
7 |
2.41 |
ng/ml/h |
0.58 |
1.53 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52900 |
482 |
FHH-Chr 15BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
9 |
0.32 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52244 |
482 |
FHH-Chr 15BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
9 |
2.36 |
ml/min |
0.15 |
0.46 |
urine creatinine analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52340 |
482 |
FHH-Chr 15BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
9 |
73.05 |
mg/d |
23.6 |
70.81 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52387 |
482 |
FHH-Chr 15BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
-7.7 |
null |
0.06 |
0.19 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56078 |
522 |
FHH-Chr 15BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
9 |
166.6 |
g |
3.2 |
9.7 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55175 |
522 |
FHH-Chr 15BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
-7.07 |
null |
0.07 |
0.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56907 |
522 |
FHH-Chr 15BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
0.82 |
g/mg |
0.12 |
0.35 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57326 |
522 |
FHH-Chr 15BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
7 |
0.26 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52265 |
482 |
FHH-Chr 15BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
-7.71 |
null |
0.12 |
0.35 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56097 |
522 |
FHH-Chr 15BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
9 |
218.3 |
g |
7.5 |
22.5 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55158 |
522 |
FHH-Chr 15BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
1.02 |
E-7mole |
0.2 |
0.59 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56493 |
522 |
FHH-Chr 15BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
7 |
132.56 |
mmHg |
2.89 |
7.65 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52553 |
482 |
FHH-Chr 15BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
9 |
1.44 |
mEq/d |
0.05 |
0.16 |
flame atomic emission spectrometry |
|
0 |
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52293 |
482 |
FHH-Chr 15BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
7 |
396.79 |
beats/min |
11.52 |
30.48 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52506 |
482 |
FHH-Chr 15BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
7 |
37.96 |
mg/d |
6.1 |
16.13 |
automated urine total protein analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52116 |
482 |
FHH-Chr 15BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
7 |
17.44 |
mEq/d |
3.27 |
8.66 |
flame atomic emission spectrometry |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52802 |
482 |
FHH-Chr 15BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
0.93 |
E-7mole |
0.13 |
0.38 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56512 |
522 |
FHH-Chr 15BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
7 |
2.4 |
ml/min |
0.46 |
1.23 |
urine creatinine analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52361 |
482 |
FHH-Chr 15BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
86.44 |
% |
3.85 |
11.54 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54772 |
522 |
FHH-Chr 15BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
7 |
36.68 |
mg/d |
12.67 |
33.51 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52408 |
482 |
FHH-Chr 15BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
7 |
1.1 |
mEq/d |
0.16 |
0.43 |
flame atomic emission spectrometry |
|
0 |
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52314 |
482 |
FHH-Chr 15BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
6 |
77.67 |
% |
5.9 |
14.46 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54753 |
522 |
FHH-Chr 15BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
0.62 |
g/mg |
0.07 |
0.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57307 |
522 |